Endometrial Cancer Trial, Recruiting NCT06877572 Sponsor: University of Kansas Medical Center Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06877572
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People with a body mass index (BMI) of 30 or higher (a measure of body weight relative to height)
  • People who have completed surgery to check the extent of their cancer, with no signs of remaining disease
  • People diagnosed with a specific type of uterine cancer called endometrioid endometrial adenocarcinoma, with a normal (wild type) p53 gene result
  • People whose cancer is classified as Stage 1 (the earliest stage, meaning it has not spread beyond the uterus)
  • People whose treatment plan involves monitoring (active surveillance) with or without a type of internal radiation therapy called brachytherapy
  • People with an ECOG performance status of 0–2, meaning they are able to carry out daily activities independently or with only some limitation (confirm with trial site)

Who may not be able to join:

  • People who are unable to take part in a structured weight loss behaviour program
  • People who have had a stroke, heart attack, severe liver disease, or severe kidney disease within the last 6 months
  • People who are currently taking a GLP-1 agonist medication (a type of drug sometimes used for diabetes or weight management, such as semaglutide or liraglutide)
  • People who are currently using insulin

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 913-588-0885

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Kansas Medical Center
Registry
ClinicalTrials.gov
Start date
25 March 2025
Est. completion
1 October 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of participants referred to weight loss clinic who are able to start weight management medications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov